Pharmacogenomic samples, testing and data handling - Scientific guideline

Human Scientific guidelines

This document highlights some key principles to be considered by both the pharmaceutical industry and the assessors for pharmacogenomics sampling in clinical trials intended for regulatory submission.

Keywords: Pharmacogenomics (PG), pharmacogenomic evaluation

Current effective version

Document history - First version (current)

Share this page